Literature DB >> 25673177

Romo1 and the NF-κB pathway are involved in oxidative stress-induced tumor cell invasion.

Sora Lee1, Yoon Hee Park1, Jin Sil Chung1, Young Do Yoo1.   

Abstract

Reactive oxygen species (ROS) are important contributors to tumor cell invasion. ROS enhanced by reactive oxygen species modulator 1 (Romo1) expression has been reported to increase invasive potential and constitutive activation of nuclear factor-κB (NF-κB) in hepatocellular carcinoma (HCC). Therefore, we investigated whether constitutive NF-κB activation due to Romo1 expression is associated with breast cancer tumor cell invasion. In this study, we show that oxidative stress-induced invasion is mediated by Romo1 expression. The Romo1-induced increase of invasive activity was blocked by an inhibitor of κB kinase (IKK). These results demonstrate that tumor cell invasion in response to oxidative stress is associated with Romo1 expression and the NF-κB signaling pathway. Romo1 is therefore a promising therapeutic target for diseases characterized by NF-κB deregulation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25673177     DOI: 10.3892/ijo.2015.2889

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  14 in total

1.  Diagnostic and prognostic role of TFF3, Romo-1, NF-кB and SFRP4 as biomarkers for endometrial and ovarian cancers: a prospective observational translational study.

Authors:  Hasan Turan; Salvatore Giovanni Vitale; Ilker Kahramanoglu; Luigi Della Corte; Pierluigi Giampaolino; Asli Azemi; Sinem Durmus; Veysel Sal; Nedim Tokgozoglu; Tugan Bese; Macit Arvas; Fuat Demirkiran; Remise Gelisgen; Sennur Ilvan; Hafize Uzun
Journal:  Arch Gynecol Obstet       Date:  2022-04-24       Impact factor: 2.344

2.  Reactive oxygen species modulator-1 (Romo1) predicts unfavorable prognosis in colorectal cancer patients.

Authors:  Hong Jun Kim; Min Jee Jo; Bo Ram Kim; Jung Lim Kim; Yoon A Jeong; Yoo Jin Na; Seong Hye Park; Suk-Young Lee; Dae-Hee Lee; Hye Seung Lee; Baek-Hui Kim; Sun Il Lee; Byung Wook Min; Young Do Yoo; Sang Cheul Oh
Journal:  PLoS One       Date:  2017-05-04       Impact factor: 3.240

Review 3.  Reactive Oxygen Species Modulator 1 (ROMO1), a New Potential Target for Cancer Diagnosis and Treatment.

Authors:  Mohammad Amin Amini; Seyed Saman Talebi; Jamshid Karimi
Journal:  Chonnam Med J       Date:  2019-09-24

4.  AWP1 Restrains the Aggressive Behavior of Breast Cancer Cells Induced by TNF-α.

Authors:  Eun-Young Kim; Ji-Eun Kim; Bongkun Choi; Jiyeon Kweon; Si-On Park; Hee-Seop Lee; Eun-Jin Lee; Soyoon Oh; Ha Rim Shin; Hyuksu Choi; Yongsub Kim; Eun-Ju Chang
Journal:  Front Oncol       Date:  2021-03-18       Impact factor: 6.244

5.  TUG1 long non-coding RNA enlists the USF1 transcription factor to overexpress ROMO1 leading to hepatocellular carcinoma growth and metastasis.

Authors:  Shihai Liu; Jing Qiu; Weitai He; Chao Geng; Guifang He; Changchang Liu; Duo Cai; Xiangping Liu; Ben Tian; Huazheng Pan
Journal:  MedComm (2020)       Date:  2020-11-26

6.  Serum Reactive Oxygen Species Modulator 1 as a Novel Predictive Biomarker for Resected Lung Adenocarcinoma: A Retrospective Pilot Study.

Authors:  Boksoon Chang; In Kyung Hwang; Seung Hyeun Lee
Journal:  Onco Targets Ther       Date:  2021-10-21       Impact factor: 4.147

7.  Romo1 is a mitochondrial nonselective cation channel with viroporin-like characteristics.

Authors:  Gi Young Lee; Deok-Gyun You; Hye-Ra Lee; Sun Wook Hwang; C Justin Lee; Young Do Yoo
Journal:  J Cell Biol       Date:  2018-03-15       Impact factor: 10.539

8.  Overexpression of Romo1 is an unfavorable prognostic biomarker and a predictor of lymphatic metastasis in non-small cell lung cancer patients.

Authors:  Hong Jun Kim; Min Jee Jo; Bo Ram Kim; Jung Lim Kim; Yoon A Jeong; Yoo Jin Na; Seong Hye Park; Suk-Young Lee; Dae-Hee Lee; Baek-Hui Kim; Young Do Yoo; Sang Cheul Oh
Journal:  Onco Targets Ther       Date:  2018-07-23       Impact factor: 4.147

9.  Overexpression of reactive oxygen species modulator 1 is associated with advanced grades of bladder cancer.

Authors:  Hadi Ghasemi; Mohammad Amin Amini; Atefeh Pegah; Ebrahim Azizi; Heidar Tayebinia; Shima Khanverdilou; Seyed Habibollah Mousavibahar; Aida Alizamir
Journal:  Mol Biol Rep       Date:  2020-08-08       Impact factor: 2.316

10.  Romo1 is involved in the immune response of glioblastoma by regulating the function of macrophages.

Authors:  Guan Sun; Ying Cao; Chunfa Qian; Zhengqiang Wan; Jian Zhu; Jun Guo; Lei Shi
Journal:  Aging (Albany NY)       Date:  2020-01-16       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.